CEO Yehiel Tal highlighted advancements in CollPlant's proprietary photocurable dermal filler, emphasizing its potential as a game-changer in the $6.3 billion market for aesthetic medicine.

When placing dental implants, practitioners should consider using Botox and dermal filler agents for patients who need facial volume restorations, according to a presentation at the American Academy ...

REHOVOT, Israel, May 28, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...

Binary News Network is a Content Syndication Platform that allows businesses or proprietary newswires to bring visibility to their content by syndicating it to premium, high-visibility networks and ...